DIPG-22. A PHASE 1 TRIAL OF THE HISTONE DEACETYLASE INHIBITOR PANOBINOSTAT IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY DIFFUSE INTRINSIC PONTINE GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) is a lethal childhood cancer with a median overall survival (OS) of 10 months and a post-progression survival (PPS) of 2–3 months. Panobinostat (LBH589) is a multi-histone deacetylase inhibitor with activity against preclinical models of DIPG. The...

詳細記述

保存先:
書誌詳細
出版年:Neuro Oncol
主要な著者: Cooney, Tabitha, Onar-Thomas, Arzu, Huang, Jie, Lulla, Rishi, Fangusaro, Jason, Kramer, Kim, Baxter, Patricia, Fouladi, Maryam, Dunkel, Ira J, Warren, Katherine E, Monje, Michelle
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2018
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012894/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.115
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料